Please assess the completion status of the following clinical trial:

Trial Title: Impact of Tomotherapy on Xerostomia and Quality of Life of Patients With Cancer of the Upper Aero-digestive Tract

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patient (e) old (e) over 18 years~* Patients with squamous cell carcinoma of head and neck (oral cavity, oropharynx, lymphadenopathy without gateway) histologically proven.~* Patient targeted for head and neck radiotherapy by Tomotherapy exclusive with or without concurrent chemotherapy (containing platinum)~* Indication of head and neck radiotherapy bilateral~* All of the TNM stage except metastatic~* Patient has signed informed consent for participation in the study~* Mastery of the French language~Exclusion Criteria:~* History of head and neck radiotherapy~* Indication of head and neck radiotherapy unilateral~* Personal history of malignant tumors uncontrolled over the past 5 years~* History of oral sicca syndrome~* Surgical removal of one or more salivary glands (parotid, submandibular gland, sublingual gland)~* Concomitant treatment with amifostine~* Concomitant treatment with cetuximab~* Primary tumor of the salivary glands~* Head and neck hyperfractionated radiotherapy and / or accelerated~* Head and neck radiotherapy hypofractionated~* Metastatic disease~* Patient deprived of liberty, under guardianship~* Any medical condition or psychological associate that could compromise the patient's ability to participate in the study~* Refusal of the patient.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).